160 related articles for article (PubMed ID: 34192867)
1. Chemoproteomic Study Uncovers HemK2/KMT9 As a New Target for NTMT1 Bisubstrate Inhibitors.
Chen D; Meng Y; Yu D; Noinaj N; Cheng X; Huang R
ACS Chem Biol; 2021 Jul; 16(7):1234-1242. PubMed ID: 34192867
[TBL] [Abstract][Full Text] [Related]
2. Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.
Chen D; Dong C; Dong G; Srinivasan K; Min J; Noinaj N; Huang R
J Med Chem; 2020 Aug; 63(15):8419-8431. PubMed ID: 32605369
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors.
Zhang G; Richardson SL; Mao Y; Huang R
Org Biomol Chem; 2015 Apr; 13(14):4149-54. PubMed ID: 25712161
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Bisubstrate Inhibitors for Protein N-Terminal Methyltransferase 1.
Chen D; Dong G; Noinaj N; Huang R
J Med Chem; 2019 Apr; 62(7):3773-3779. PubMed ID: 30883119
[TBL] [Abstract][Full Text] [Related]
5. Selective Peptidomimetic Inhibitors of NTMT1/2: Rational Design, Synthesis, Characterization, and Crystallographic Studies.
Mackie BD; Chen D; Dong G; Dong C; Parker H; Schaner Tooley CE; Noinaj N; Min J; Huang R
J Med Chem; 2020 Sep; 63(17):9512-9522. PubMed ID: 32689795
[TBL] [Abstract][Full Text] [Related]
6. Development of rationally designed DNA N6 adenine methyltransferase inhibitors.
Hobley G; McKelvie JC; Harmer JE; Howe J; Oyston PC; Roach PL
Bioorg Med Chem Lett; 2012 May; 22(9):3079-82. PubMed ID: 22483584
[TBL] [Abstract][Full Text] [Related]
7. Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1.
Dong G; Iyamu ID; Vilseck JZ; Chen D; Huang R
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209173
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship investigation of adenosine-containing inhibitors of histone methyltransferase DOT1L.
Anglin JL; Deng L; Yao Y; Cai G; Liu Z; Jiang H; Cheng G; Chen P; Dong S; Song Y
J Med Chem; 2012 Sep; 55(18):8066-74. PubMed ID: 22924785
[TBL] [Abstract][Full Text] [Related]
9. Venglustat Inhibits Protein N-Terminal Methyltransferase 1 in a Substrate-Competitive Manner.
Dong G; Deng Y; Yasgar A; Yadav R; Talley D; Zakharov AV; Jain S; Rai G; Noinaj N; Simeonov A; Huang R
J Med Chem; 2022 Sep; 65(18):12334-12345. PubMed ID: 36074125
[TBL] [Abstract][Full Text] [Related]
10. Comparative Analysis of Two NNMT Bisubstrate Inhibitors through Chemoproteomic Studies: Uncovering the Role of Unconventional SAM Analogue Moiety for Improved Selectivity.
Meng Y; Iyamu ID; Ahmed NAM; Huang R
ACS Chem Biol; 2024 Jan; 19(1):89-100. PubMed ID: 38181447
[TBL] [Abstract][Full Text] [Related]
11. Distinct specificities of the HEMK2 protein methyltransferase in methylation of glutamine and lysine residues.
Weirich S; Ulu GT; Chandrasekaran TT; Kehl J; Schmid J; Dorscht F; Kublanovsky M; Levy D; Jeltsch A
Protein Sci; 2024 Feb; 33(2):e4897. PubMed ID: 38284488
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Drug Design of Bisubstrate Inhibitors of Phenylethanolamine
Lu J; Bart AG; Wu Q; Criscione KR; McLeish MJ; Scott EE; Grunewald GL
J Med Chem; 2020 Nov; 63(22):13878-13898. PubMed ID: 33147410
[TBL] [Abstract][Full Text] [Related]
13. KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells.
Metzger E; Wang S; Urban S; Willmann D; Schmidt A; Offermann A; Allen A; Sum M; Obier N; Cottard F; Ulferts S; Preca BT; Hermann B; Maurer J; Greschik H; Hornung V; Einsle O; Perner S; Imhof A; Jung M; Schüle R
Nat Struct Mol Biol; 2019 May; 26(5):361-371. PubMed ID: 31061526
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibitors of bacterial DNA adenine methyltransferases.
Mashhoon N; Pruss C; Carroll M; Johnson PH; Reich NO
J Biomol Screen; 2006 Aug; 11(5):497-510. PubMed ID: 16760373
[TBL] [Abstract][Full Text] [Related]
15. Exploring Unconventional SAM Analogues To Build Cell-Potent Bisubstrate Inhibitors for Nicotinamide N-Methyltransferase.
Iyamu ID; Vilseck JZ; Yadav R; Noinaj N; Huang R
Angew Chem Int Ed Engl; 2022 Apr; 61(16):e202114813. PubMed ID: 35134268
[TBL] [Abstract][Full Text] [Related]
16. Comparative Study of Adenosine Analogs as Inhibitors of Protein Arginine Methyltransferases and a
Zhou J; Deng Y; Iyamu ID; Horton JR; Yu D; Hajian T; Vedadi M; Rotili D; Mai A; Blumenthal RM; Zhang X; Huang R; Cheng X
ACS Chem Biol; 2023 Apr; 18(4):734-745. PubMed ID: 37082867
[No Abstract] [Full Text] [Related]
17. Structural insight into HEMK2-TRMT112-mediated glutamine methylation.
Gao J; Wang B; Yu H; Wu G; Wan C; Liu W; Liao S; Cheng L; Zhu Z
Biochem J; 2020 Oct; 477(19):3833-3838. PubMed ID: 32969463
[TBL] [Abstract][Full Text] [Related]
18. Kinetic mechanism of protein N-terminal methyltransferase 1.
Richardson SL; Mao Y; Zhang G; Hanjra P; Peterson DL; Huang R
J Biol Chem; 2015 May; 290(18):11601-10. PubMed ID: 25771539
[TBL] [Abstract][Full Text] [Related]
19. Bisubstrate inhibitors for the enzyme catechol-O-methyltransferase (COMT): influence of inhibitor preorganisation and linker length between the two substrate moieties on binding affinity.
Lerner C; Masjost B; Ruf A; Gramlich V; Jakob-Roetne R; Zürcher G; Borroni E; Diederich F
Org Biomol Chem; 2003 Jan; 1(1):42-9. PubMed ID: 12929389
[TBL] [Abstract][Full Text] [Related]
20. Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.
Deng Y; Deng S; Ho YH; Gardner SM; Huang Z; Marmorstein R; Huang R
J Med Chem; 2021 Jun; 64(12):8263-8271. PubMed ID: 34110812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
